Works matching DE "CLARITHROMYCIN"

Results: 1624

Comment on "Drug-Induced Cognitive Impairment".

Published in:

Drug Safety, 2025, v. 48, n. 7, p. 839, doi. 10.1007/s40264-025-01567-0

By:

Ben Salem, Chaker

Publication type:

Article

Towards shortening the duration of antibiotic therapy for Lyme borreliosis: a systematic review and meta-analysis.

Published in:

Infection, 2025, v. 53, n. 3, p. 809, doi. 10.1007/s15010-025-02501-3

By:

Raffetin, Alice;
Henningsson, Anna J.;
Ornstein, Katharina;
Arias, Pauline;
Fingerle, Volker;
Patrat-Delon, Solene;
Bremell, Daniel;
Lindgren, Per Eric;
Rupprecht, Tobias A.;
Jaulhac, Benoît;
Hunfeld, Klaus-Peter;
Cazorla, Céline;
Markowicz, Mateusz;
Lienhard, Reto;
van Dam, Alje P.;
Baux, Elisabeth;
Mavin, Sally;
Hovius, Joppe W.;
Baarsma, M. E.;
Berg, Kristine Karlsrud

Publication type:

Article

Correction to: A single upstream mutation of whiB7 underlies amikacin and clarithromycin resistance in Mycobacterium abscessusFree.

Published in:: 2025
Publication type:: Correction Notice

Surgical Site Infections Caused by Rapidly Growing Nontuberculous Mycobacteria: an Under-Recognized and Misdiagnosed Entity.

Published in:

Indian Journal of Surgery, 2021, v. 83, n. 2, p. 418, doi. 10.1007/s12262-020-02383-9

By:

Choudhary, Ashwini;
Gopalakrishnan, R.;
Senthur Nambi, P.;
Thirunarayan, M. A.;
Ramasubramanian, V.;
Sridharan, Sowmya

Publication type:

Article

Total Synthesis of Mycinamicin IV as Integral Part of a Collective Approach to Macrolide Antibiotics.

Published in:

Chemistry - A European Journal, 2022, v. 28, n. 10, p. 1, doi. 10.1002/chem.202104400

By:

Späth, Georg;
Fürstner, Alois

Publication type:

Article

Total Synthesis of Tiacumicin B: Study of the Challenging β‐Selective Glycosylations*.

Published in:

Chemistry - A European Journal, 2021, v. 27, n. 16, p. 5230, doi. 10.1002/chem.202005102

By:

Tresse, Cédric;
François‐Heude, Marc;
Servajean, Vincent;
Ravinder, Rubal;
Lesieur, Clémence;
Geiben, Lucie;
Jeanne‐Julien, Louis;
Steinmetz, Vincent;
Retailleau, Pascal;
Roulland, Emmanuel;
Beau, Jean‐Marie;
Norsikian, Stéphanie

Publication type:

Article

Frontispiece: The Nargenicin Family of Oxa‐Bridged Macrolide Antibiotics.

Published in:

Chemistry - A European Journal, 2020, v. 26, n. 13, p. 1, doi. 10.1002/chem.202081362

By:

Pidot, Sacha J.;
Rizzacasa, Mark A.

Publication type:

Article

The Nargenicin Family of Oxa‐Bridged Macrolide Antibiotics.

Published in:

Chemistry - A European Journal, 2020, v. 26, n. 13, p. 2780, doi. 10.1002/chem.201904053

By:

Pidot, Sacha J.;
Rizzacasa, Mark A.

Publication type:

Article

The effects of drug-drug interaction on linezolid pharmacokinetics: A systematic review.

Published in:

European Journal of Clinical Pharmacology, 2024, v. 80, n. 6, p. 785, doi. 10.1007/s00228-024-03652-2

By:

Xu, Qiang;
Sang, Yanlei;
Gao, Anna;
Li, Lu

Publication type:

Article

Physiologically based pharmacokinetic combined BTK occupancy modeling for optimal dosing regimen prediction of acalabrutinib in patients alone, with different CYP3A4 variants, co-administered with CYP3A4 modulators and with hepatic impairment.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 9, p. 1435, doi. 10.1007/s00228-022-03338-7

By:

Xu, Lifang;
Yu, Shuang;
Liu, Huining;
Yi, Bowen;
Wang, Guopeng;
Liu, Yang

Publication type:

Article

Physiologically based pharmacokinetic modelling to predict the clinical effect of CYP3A inhibitors/inducers on esaxerenone pharmacokinetics in healthy subjects and subjects with hepatic impairment.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 1, p. 65, doi. 10.1007/s00228-021-03194-x

By:

Watanabe, Akiko;
Ishizuka, Tomoko;
Yamada, Makiko;
Igawa, Yoshiyuki;
Shimizu, Takako;
Ishizuka, Hitoshi

Publication type:

Article

Optimizing the MIC breakpoints of amoxicillin and tetracycline for antibiotic selection in the rescue therapy of H. pylori with bismuth quadruple regimen.

Published in:

European Journal of Clinical Pharmacology, 2020, v. 76, n. 11, p. 1581, doi. 10.1007/s00228-020-02938-5

By:

Hsieh, Ming-Tsung;
Chang, Wei-Lun;
Wu, Chung-Tai;
Yang, Hsiao-Bai;
Kuo, Hsin-Yu;
Lin, Meng-Ying;
Cheng, Hsiu-Chi;
Tsai, Yu-Chin;
Sheu, Bor-Shyang

Publication type:

Article

The parent drugs chloroquine and hydroxychloroquine do not inhibit human CYP3A activity in vitro.

Published in:

2020

By:

Li, Xia;
Höhl, Rainer;
Sörgel, Fritz;
Fuhr, Uwe

Publication type:

Letter

Saccharomyces boulardii CNCM I-745 plus sequential therapy for Helicobacter pylori infections: a randomized, open-label trial.

Published in:

European Journal of Clinical Pharmacology, 2019, v. 75, n. 5, p. 639, doi. 10.1007/s00228-019-02625-0

By:

Seddik, Hassan;
Boutallaka, Hanae;
Elkoti, Ilham;
Nejjari, Fouad;
Berraida, Reda;
Berrag, Sanaa;
Loubaris, Khaoula;
Sentissi, Sara;
Benkirane, Ahmed

Publication type:

Article

Pharmacokinetic drug interaction and safety after coadministration of clarithromycin, amoxicillin, and ilaprazole: a randomised, open-label, one-way crossover, two parallel sequences study.

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 9, p. 1149, doi. 10.1007/s00228-018-2489-2

By:

Jin, Byung Hak;
Yoo, Byung Won;
Park, Jungsin;
Kim, Jung Hye;
Lee, Jun Yeon;
Shin, Jae Soo;
Park, Min Soo

Publication type:

Article

Assessment of inter-racial variability in CYP3A4 activity and inducibility among healthy adult males of Caucasian and South Asian ancestries.

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 7, p. 913, doi. 10.1007/s00228-018-2450-4

By:

van Dyk, Madelé;
Marshall, Jean-Claude;
Sorich, Michael J;
Wood, Linda S.;
Rowland, Andrew

Publication type:

Article

Application of physiologically based pharmacokinetic modeling to the prediction of drug-drug and drug-disease interactions for rivaroxaban.

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 6, p. 755, doi. 10.1007/s00228-018-2430-8

By:

Xu, Ruijuan;
Ge, Weihong;
Jiang, Qing

Publication type:

Article

Sequential versus concomitant therapy for treatment of Helicobacter pylori infection: an updated systematic review and meta-analysis.

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 1, p. 1, doi. 10.1007/s00228-017-2347-7

By:

Wang, Youhua;
Zhao, Rulin;
Wang, Ben;
Zhao, Qiaoyun;
Li, Zhen;
Zhu-ge, Liya;
Yin, Wenzhu;
Xie, Yong

Publication type:

Article

Interaction of ambrisentan with clarithromycin and its modulation by polymorphic SLCO1B1.

Published in:

European Journal of Clinical Pharmacology, 2013, v. 69, n. 10, p. 1785, doi. 10.1007/s00228-013-1529-1

By:

Markert, Christoph;
Hellwig, Regina;
Burhenne, Jürgen;
Hoffmann, Michael;
Weiss, Johanna;
Mikus, Gerd;
Haefeli, Walter

Publication type:

Article

Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a prospective randomized study.

Published in:

European Journal of Clinical Pharmacology, 2013, v. 69, n. 9, p. 1709, doi. 10.1007/s00228-013-1524-6

By:

Seddik, Hassan;
Ahid, Samir;
Adioui, Tarek;
Hamdi, Fatim-Zohra;
Hassar, Mohammed;
Abouqal, Redouane;
Cherrah, Yahia;
Benkirane, Ahmed

Publication type:

Article

Rate of onset of inhibition of gut-wall and hepatic CYP3A by clarithromycin.

Published in:

European Journal of Clinical Pharmacology, 2013, v. 69, n. 3, p. 439, doi. 10.1007/s00228-012-1339-x

By:

Quinney, Sara;
Malireddy, Srikar;
Vuppalanchi, Raj;
Hamman, Mitchell;
Chalasani, Naga;
Gorski, J.;
Hall, Stephen

Publication type:

Article

Effect of clarithromycin and fluconazole on the pharmacokinetics of montelukast in human volunteers.

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 9, p. 1275, doi. 10.1007/s00228-012-1239-0

By:

Hegazy, Sahar;
Mabrouk, Mokhtar;
Elsisi, Alaa;
Mansour, Noha

Publication type:

Article

Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 5, p. 479, doi. 10.1007/s00228-011-1161-x

By:

Zarogoulidis, P.;
Papanas, N.;
Kioumis, I.;
Chatzaki, E.;
Maltezos, E.;
Zarogoulidis, K.

Publication type:

Article

Detection of Clarithromycin Resistance in Helicobacter pylori Using MmaxSure™ H. pylori & ClaR Assay.

Published in:

Digestive Diseases, 2024, v. 42, n. 4, p. 292, doi. 10.1159/000538655

By:

Kim, Ilsoo;
Shin, Yu Ri;
Kim, Joon Sung;
Kim, Byung-Wook;
Maeng, Lee-So;
Kim, Jung Min

Publication type:

Article

Prevalence of Clarithromycin-Resistant Helicobacter pylori Strains in Zambia: A Sub-Saharan African Country.

Published in:

Digestive Diseases, 2024, v. 42, n. 2, p. 154, doi. 10.1159/000535454

By:

Kebotsamang, Tshegofatso;
Munkombwe, Derick;
Bwalya, Lalusha;
Kelly, Paul;
Kayamba, Violet

Publication type:

Article

Dual Clarithromycin and Metronidazole Resistance Is the Main Cause of Failure in Ultimate Helicobacter pylori Eradication.

Published in:

Digestive Diseases, 2021, v. 39, n. 5, p. 451, doi. 10.1159/000514278

By:

Hwang, Ji Yong;
Kim, Changho;
Kwon, Yong Hwan;
Lee, Ji Eun;
Jeon, Seong Woo;
Nam, Su Youn;
Seo, An Na;
Han, Man-Hoon;
Park, Ji Hye

Publication type:

Article

Helicobacter pylori Eradication Rates in Slovenia in the Period from 2017 to 2019: Data from the European Registry on H. pylori Management.

Published in:

Digestive Diseases, 2021, v. 39, n. 4, p. 318, doi. 10.1159/000512506

By:

Tepes, Bojan;
Brglez Jurecic, Natasa;
Tepes, Katja;
Espada Sanchez, Marta;
Perez Nyssen, Olga;
O'Morain, Colm;
Mégraud, Francis;
Gisbert, Javier

Publication type:

Article

Surveillance of the Antimicrobial Resistance Rates of Helicobacter pylori Ten Years Later in the Western Central Region, Colombia.

Published in:

Digestive Diseases, 2020, v. 38, n. 3, p. 196, doi. 10.1159/000503381

By:

Bedoya-Gómez, Ingrid Johanna;
Alvarez-Aldana, Adalucy;
Moncayo-Ortiz, José Ignacio;
Guaca-González, Yina Marcela;
Santacruz-Ibarra, Jorge Javier;
Arturo-Arias, Brenda Lucia;
Castañeda-Chávez, Luis Javier;
Leon Rodriguez, Daniel Arturo;
Beltrán-Angarita, Leonardo

Publication type:

Article

Evaluation of the effectiveness of using two different probiotics in helicobacter eradication treatment.

Published in:

Laparoscopic Endoscopic Surgical Science, 2021, v. 28, n. 4, p. 176, doi. 10.14744/less.2021.03764

By:

Koca, Bülent;
Kılıç, Erol;
Yürüker, Saim Savaş;
Yıldırım, Murat;
Bostan, Mustafa Sami;
Uğurlu, Celil;
Özkan, Namık

Publication type:

Article

In silico Analysis of Virulence, Resistance Genes and Phylogeny of Helicobacter pylori Strains from Different Continents.

Published in:

Experimed, 2021, v. 11, n. 3, p. 170, doi. 10.26650/experimed.2021.970580

By:

Demirci, Mehmet;
Ünlü, Özge;
Kocazeybek, Bekir S.

Publication type:

Article

Single and combined toxic effects of clarithromycin and levofloxacin on Microcystis aeruginosa.

Published in:

Environmental Pollutants & Bioavailability, 2022, v. 34, n. 1, p. 482, doi. 10.1080/26395940.2022.2130825

By:

Wu, Yixiao;
Ding, Huijun;
Wan, Liang;
Zhang, Weihao;
Zhang, Yan;
Yang, Lin;
Zhao, Chong

Publication type:

Article

Treatment failure of Helicobacter pylori in primary care: a retrospective cohort study.

Published in:

BJGP Open, 2024, v. 8, n. 3, p. 1, doi. 10.3399/BJGPO.2023.0252

By:

van den Brink, Gertrude;
Koggel, Lieke M.;
Hendriks, Joris J. H.;
de Boer, Mark G. J.;
Siersema, Peter D.;
Numans, Mattijs E.

Publication type:

Article

Anti–Helicobacter pylori Treatment in Patients With Gastric Cancer After Radical Gastrectomy.

Published in:

JAMA Network Open, 2024, v. 7, n. 3, p. e243812, doi. 10.1001/jamanetworkopen.2024.3812

By:

Zhao, Zhoukai;
Zhang, Ruopeng;
Chen, Guoming;
Nie, Man;
Zhang, Feiyang;
Chen, Xiaojiang;
Lin, Jun;
Chen, Zewei;
Lin, Feizhi;
Wei, Chengzhi;
Zheng, Ziqi;
Ruan, Shenghang;
Huang, Bowen;
Chen, Yingbo;
Nie, Runcong

Publication type:

Article

Clarithromycin as an adjunct to periodontal therapy: a systematic review and meta‐analysis.

Published in:

International Journal of Dental Hygiene, 2022, v. 20, n. 1, p. 75, doi. 10.1111/idh.12498

By:

Bashir, Nasir Zeeshan;
Sharma, Praveen

Publication type:

Article

Helicobacter pylori Eradication According to Sequencing-Based 23S Ribosomal RNA Point Mutation Associated with Clarithromycin Resistance.

Published in:

Journal of Clinical Medicine, 2020, v. 9, n. 1, p. 54, doi. 10.3390/jcm9010054

By:

Seo, Seung In;
Do, Byoung Joo;
Kang, Jin Gu;
Kim, Hyoung Su;
Jang, Myoung Kuk;
Kim, Hak Yang;
Shin, Woon Geon

Publication type:

Article

A Case of Opportunity: M. marinum.

Published in:

Journal of Continuing Education Topics & Issues, 2018, v. 20, n. 3, p. 72

By:

Johnson, Deborah A.;
Barham, Dr. Beverly J.;
Webster, Kathryn E.

Publication type:

Article

Correlation of registered drug packs in Greece with Maastricht V/Florence and Hellenic Helicobacter pylori infection treatment consensuses: A poor or a proper match?

Published in:

Basic & Clinical Pharmacology & Toxicology, 2020, v. 127, n. 1, p. 6, doi. 10.1111/bcpt.13416

By:

Liatsos, Christos;
Papaefthymiou, Apostolis;
Kyriakos, Nikolaos;
Giakoumis, Marios;
Galanopoulos, Michail;
Petridou, Evangelia;
Doulberis, Michael;
Kountouras, Jannis

Publication type:

Article

Response to the Letter to the Editor entitled "Correlation of registered drug packs in Greece with Maastricht V/Florence and Hellenic Helicobacter pylori infection treatment Consensuses: A poor or a proper match?".

Published in:

Basic & Clinical Pharmacology & Toxicology, 2020, v. 127, n. 1, p. 8, doi. 10.1111/bcpt.13420

By:

Jukic, Ivana;
Rusic, Doris;
Vukovic, Jonatan;
Modun, Darko

Publication type:

Article

Interaction potential between clarithromycin and individual statins—A systematic review.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2020, v. 126, n. 4, p. 307, doi. 10.1111/bcpt.13343

By:

Hougaard Christensen, Mette Marie;
Bruun Haastrup, Maija;
Øhlenschlæger, Thomas;
Esbech, Peter;
Arnspang Pedersen, Sidsel;
Bach Dunvald, Ann‐Cathrine;
Bjerregaard Stage, Tore;
Pilsgaard Henriksen, Daniel;
Thestrup Pedersen, Andreas James

Publication type:

Article

HLA‐A*02:07 Allele Associates with Clarithromycin‐Induced Cutaneous Adverse Drug Reactions in Chinese Patients.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2018, v. 123, n. 3, p. 308, doi. 10.1111/bcpt.13011

By:

Chen, Sheng‐An;
Yang, Fan‐Ping;
Chen, Zi‐Hua;
Xiong, Hao;
Luo, Xiao‐Qun;
Zhang, Li‐Rong;
Yang, Lin‐Lin;
Yang, Ying;
Jiang, Meng‐Lin;
Zhu, Hui‐Zhong;
Qi, Zheng;
Xing, Qing‐He

Publication type:

Article

Clarithromycin Suppresses Apple Proliferation Phytoplasma in Explant Cultures.

Published in:

Plants (2223-7747), 2023, v. 12, n. 22, p. 3820, doi. 10.3390/plants12223820

By:

Semerák, Matěj;
Sedlák, Jiří;
Čmejla, Radek

Publication type:

Article

Targeting potassium channels and autophagy to defeat chemoresistance.

Published in:

Molecular & Cellular Oncology, 2020, v. 7, n. 3, p. 1, doi. 10.1080/23723556.2020.1745038

By:

Petroni, Giulia

Publication type:

Article

Occurrence of Ureaplasma urealyticumin in Women in the Northeast of Iran: Characterization of Resistance Trends.

Published in:

International Journal of Women's Health & Reproduction Sciences, 2021, v. 9, n. 4, p. 274, doi. 10.15296/ijwhr.2021.50

By:

Mardaneh, Jalal;
Mohammadzadeh, Alireza;
Alavi, Mahdieh Sadat;
Zendehdel, Mahdieh;
Bahri, Narjes;
Mehraban, Mehrnaz;
Ardebili, Abdollah;
Pouladfar, Gholamreza;
Anvarinejad, Mojtaba

Publication type:

Article

The Effects of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Volunteers: A Single-Sequence Crossover Study.

Published in:

American Journal of Cardiovascular Drugs, 2019, v. 19, n. 6, p. 561, doi. 10.1007/s40256-019-00348-2

By:

Garonzik, Samira;
Byon, Wonkyung;
Myers, Elsa;
Li, Xiodong;
Marchisin, David;
Murthy, Bindu

Publication type:

Article

A Case of Clarithromycin-induced Eosinophilic Pneumonia and Myocarditis.

Published in:

Journal of Turgut Ozal Medical Center, 2015, v. 22, n. 2, p. 131, doi. 10.7247/jtomc.2014.2052

By:

Kılıç, Talat;
Yıldırım, Zeki;
Topal, Ergün

Publication type:

Article

Remission of ALK-negative primary pulmonary inflammatory myofibroblastic tumor on treatment with clarithromycin: A case report and review of the literature.

Published in:

2016

By:

HIDEHIRO WATANABE;
TOMONORI URUMA;
GEN TAZAKI;
TAKUMA TAJIRI;
RYOTA KIKUCHI;
MASAYUKI ITOH;
KAZUTETSU AOSHIBA;
HIROYUKI NAKAMURA

Publication type:

Case Study

Association Between Acute Neuropsychiatric Events and Helicobacter pylori Therapy Containing Clarithromycin.

Published in:

2016

By:

Wong, Angel Y. S.;
Wong, Ian C. K.;
Chui, Celine S. L.;
Lee, Edwin H. M.;
Chang, W. C.;
Chen, Eric Y. H.;
Leung, Wai K.;
Chan, Esther W.

Publication type:

journal article

Sex-specific Differences in Response to First-line Helicobacter pylori Eradication Therapy with Vonoprazan, Amoxicillin, and Clarithromycin.

Published in:

Indonesian Journal of Gastroenterology, Hepatology & Digestive Endoscopy, 2019, v. 20, n. 3, p. 146

By:

Yusaku Kajihara

Publication type:

Article

Clarithromycin hypersensitivity in children: Is there a link with β‐lactam hypersensitivity?

Published in:

Pediatric Allergy & Immunology, 2021, v. 32, n. 8, p. 1781, doi. 10.1111/pai.13588

By:

Suleyman, Ayse;
Yucel, Esra;
Sipahi Cimen, Sevgi;
Hizli Demirkale, Zeynep;
Ozdemir, Cevdet;
Tamay, Zeynep Ulker;
Guler, Nermin;
Atanaskovic‐Markovic, Marina

Publication type:

Article

Effect of clarithromycin on acute asthma exacerbations in children: an open randomized study.

Published in:

Pediatric Allergy & Immunology, 2012, v. 23, n. 4, p. 385, doi. 10.1111/j.1399-3038.2012.01280.x

By:

Koutsoubari, Ioanna;
Papaevangelou, Vassiliki;
Konstantinou, George N.;
Makrinioti, Heidi;
Xepapadaki, Paraskevi;
Kafetzis, Dimitrios;
Papadopoulos, Nikolaos G.

Publication type:

Article